Abstract
A series of novel 4,6-dimorpholinyl-1,3,5-triazine derivatives 6a–6r were obtained through N-substitution and Claisen-Schmidt condensation. 1H NMR, 13C NMR, and mass spectrometry were used to characterize the molecular structures of the derivatives. The in vitro antiproliferation activity of derivatives was evaluated using the MTT assay against SW620 (human colon cancer cells), A549 (human nonsmall cell lung cancer cells), HeLa (human cervical cancer cells), and MCF-7 (human breast cancer cells). Compound 6o bearing a pyridyl group exhibited good cytotoxicity against four cancer cells, with IC50 values of 8.71, 9.55, 15.67, and 21.77 μM, sequentially. In addition, compound 6a showed some selectivity against SW620.
摘要
通过 N-取代和 Claisen-Schmidt 缩合得到了一系列新型 4,6-二吗啉基-
1,3,5-三嗪衍
生物 6a-6r。利用 1H NMR、13C NMR 和质谱分析了这些衍
生物的分子结构。采用 M
TT 法评估了衍
生物对 SW620(人结肠癌细胞)、A549(人非小细胞肺癌细胞)、HeLa(人宫颈癌细胞)和 MCF-7(人乳腺癌细胞)的体外抗增殖活性。带有
吡啶基的化合物 6o 对四种癌细胞具有良好的细胞毒性,IC50 值依次为 8.71、9.55、15.67 和 21.77 μM。此外,化合物 6a 对 SW620 具有一定的选择性。